This suggests that the elevation of sNfL and sGFAP levels in PPMS compared to SPG4 is most pronounced in early stages of disease and lessens with age, which is in line with histopathological findings supporting dying-out of inflammatory and neurodegenerative pathology with age [23]. This evidence concerns the gene SPAST and primary progressive multiple sclerosis.